Table 2 Barriers to buprenorphine prescribing by step completed in buprenorphine training, registration, and prescribing process
| Â | Did not complete training | Did not register with DEA | Has DATA-2000, not prescribing buprenorphine | Prescribing buprenorphine |
|---|---|---|---|---|
Reimbursement concerns (n = 75) | 2 (18.2) | 1 (16.7) | 1 (3.6) | 4 (13.3) |
Prior authorization (n = 75) | 1 (9.1) | 2 (33.3) | 3 (11.1) | 4 (12.9) |
No behavioral health counseling (n = 76) | 4 (36.4) | 1 (16.7) | 9 (32.1) | 15 (48.4) |
No addiction specialist (n = 76) | 6 (50) | 3 (50) | 8 (28.6) | 13 (43.3) |
No psychiatrist (n = 75) | 5 (45.5) | 2 (33.3) | 6 (21.4) | 14 (46.7) |
No confidence in management (n = 76) | 3 (27.3) | 2 (33.3) | 4 (13.8) | 5 (16.7) |
Lack of patient demand (n = 76) | 3 (27.3) | 1 (16.7) | 14 (48.3) | 4 (13.3) |
Too many requests (n = 74) | 1 (9.1) | 0 (0) | 6 (22.2) | 2 (6.7) |
Diversion/misuse (n = 76) | 3 (25) | 2 (33.3) | 3 (10.7) | 5 (16.7) |
Prefer non-buprenorphine treatment (n = 74) | 2 (18.2) | 1 (16.7) | 2 (7.4) | 1 (3.3) |
Time constraints (n = 74) | 4 (36.4) | 1 (16.7) | 8 (29.6) | 8 (26.7) |
Institutional resistance (n = 72) | 1 (10) | 1 (16.7) | 6 (22.2) | 3 (10.3) |
DEA intrusion (n = 75) | 3 (27.3) | 3 (50) | 2 (7.1) | 4 (13.3) |